US biotech Cabaletta Bio (Nasdaq: CABA) has named ElevateBio as a second contract development and manufacturing organization ...

US cancer care biotech Werewolf Therapeutics and Ambros Therapeutics today announced that they entered into a definitive ...

Today, the US Food and Drug Administration published a new batch of draft product-specific guidances (PSGs) for developing ...

Chinese contract development and manufacturing group WuXi Biologics (HKEX: 2269) has agreed to sell its 51.1% stake in ...

The UK's cost-effectiveness watchdog has recommended US pharma major Eli Lilly's (NYSE: LLY) once-weekly basal insulin Onswik ...

Privately-held Italian drugmaker Alfasigma has entered into a share purchase agreement with SEVER Life Sciences (SEVER) for ...

Johnson & Johnson has announced that the European Commission (EC) has approved an indication extension for Tecvayli ...

UK-based specialty CNS-focused pharma company CNX Therapeutics today announced a distribution partnership with Innomar ...

Nearly eight years into the artificial intelligence (AI) drug discovery boom, no medicine discovered or designed with AI has ...

Genentech, Roche’s US biotech subsidiary, announced plans to invest approximately $750 million in a new device fill-finish ...

Charles River Laboratories International and Taiwan’s Medigen Vaccine Biologics (MVC) have announced a strategic ...

Canada-based Edesa Biotech has priced an underwritten public offering expected to generate approximately $25 million in gross ...